High Point Advisor Group LLC Compugen LTD Transaction History

High Point Advisor Group LLC

  • $1.67 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.57 - $3.33 $10,153 - $21,535
-6,467 Reduced 29.92%
15,149 $32,000
Q3 2021

Nov 15, 2021
SELL
$5.8 - $8.02 $1,061 - $1,467
-183 Reduced 0.84%
21,616 $129,000
Q2 2021

Jul 29, 2021
SELL
$6.87 - $9.16 $68 - $91
-10 Reduced 0.05%
21,799 $180,000
Q1 2021

Apr 12, 2021
BUY
$7.67 - $13.77 $167,275 - $300,309
21,809 New
21,809 $184,000

Others Institutions Holding CGEN

# of Institutions
73
Shares Held
13.1M
Call Options Held
79.2K
Put Options Held
12.7K
View Full List

About COMPUGEN LTD

CGEN Quotes by TradingView
  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $129M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email